ArticleScientific reports2022
Allocating vaccines to remote and on-site workers in the tradable sector.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccination may be the solution to the pandemic-induced health crisis, but the allocation of vaccines is a complex task in which ethical, economic and social considerations are important. The biggest challenge is to use the limited number of vaccines available in a way that protects vulnerable groups, prevents further spread of infection, and reduces economic uncertainty. We argue that once the vaccination of healthcare workers and the most vulnerable groups has been completed, prioritizing the vaccination of on-site workers is important not only to slow the spread of the infection, but also to ensure the smooth running of economic production. We propose a simple economic model where remote and on-site workers are complementary to each other in the short run, thus a negative shock to the supply of either one may decrease the demand for the other, leading to unemployment. By illustrating the model using pre-Covid employment data from Sweden and Hungary, we show that the optimal vaccine allocation between remote and on-site workers in the tradable sector should be based on different proportions depending on the relative infection risk of on-site workers and the degree of vaccine availability. As long as the number of vaccines is limited and on-site workers are at higher risk of infection, they should be preferred in general. However, as more vaccines become available, countries like Sweden, where the share of occupations that can be done remotely is higher shall start immunize remote workers. In Hungary, where on-site work is dominant in the tradable sector, continued vaccination of on-site workers is more beneficial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.